Borgess Medical Center

Kalamazooaa, Michigan 49001

0 studies enrolling now · 12 studies all time

What they study most

Anal Cancer, Bladder Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Melanoma (Skin), Metastatic Cancer, Pancreatic Cancer, Radiation Toxicity

Studies at this site

• Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer — Completed
• Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
• Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma — Completed
• S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer — Completed
• Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer — Completed
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer — Stopped early
• S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas — Completed
• Vaginal Changes and Sexual Function in Patients With Cervical Cancer — Completed
• S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer — Completed
• S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer — Withdrawn before enrolling
• S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx — Stopped early
• SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma — Completed